CYDY: Peril Report
From time to time every company needs to be reviewed for potential perils to new and existing investors. CYDY, a late stage biotech that used to claim it's products were "safe and effective," is one such company. Here are the current perils facing the company...
Current CEO
Nader "The Chipped Tooth Liar" Pourhassan, a multiple time felon for fraud, is currently engaged in fending off the SEC, DOJ, angry investors, and various lawsuits. His past behaviors included unjust enrichment at the shareholders expense. Lying about revenue, failing to hit self imposed deadlines, making multiple misstatements like "conditional EUA," and "revenue." Despite having zero approvals he at one time directed all PRs to include the statement "safe and effective" until the SEC stepped in.
No Revenue
Currently CYDY survives on issuing more shares and toxic financing. CYDY once claimed it was going to receive revenue from the Philippines until shameless liar Nader "The Chipped Tooth Liar" Pourhassan sheepishly walked back those claims. In a recent PR stunt Nader has claimed that revenue is back on the table. He has however declined to state how much revenue is being generated, how many vials sold, and if this will be a continuing revenue.
For a debt laden company like CYDY revenue is a must if it is to continue operating.
Brazil Enrollment Speed
CYDY has stated that they have recently had their first patient injected. However the company has not stated how many patients are enrolled in the Brazil trial. CYDY has historically been slow in enrolling patients and frequently misses key deadlines. CYDY's last projection is that the trial would wrap up sometime mid 2022.
Brazil Trial Results
CYDY is theorizing that 2 more doses will improve it's trial results which only saw a 30% survival rate at the 28 day mark. Should this trial fail, CYDY is out of the COVID game and will have effectively squandered cash it can't afford to.
HIV BLA MIA
CYDY currently has everyone focused on COVID. While it's quickest path to actual revenue and of course approval lies with it's HIV therapy. However there has been little to no news about the new BLA being put together. It was promised for October, however it is now 9/22/2021 and once again looks to be off schedule. The last BLA for HIV received an RTF to which Nader gave conflicting accounts.
Bankruptcy
Due to CYDY's toxic loans, cash burn rate and lack of revenue this should be self explanatory.
SEC and DOJ Investigations
Based on CYDY's own PR's, Nader's comments and filings, CYDY and it's board appear to be the subject of two major investigations. While CYDY was quick to point out the SEC has no opinions about unlawful behavior, it should also quickly pointed out the SEC only handles civil matters. That same statement by CYDY was not issued when it explained the DOJ investigation.
It should be noted that the DOJ issued subpoenas to CYDY in it's investigation into the company and board. This investigation includes Nader "The Chipped Tooth Liar" Pourhassan, who is no stranger to fraud investigations and time behind bars.
In a filing by the company on pages 125 and 126, the company has stated it can't calculate the potential financial damages to the company as a result of these two investigations.
Reddit Cult
This group formulated the harassment campaign against the FDA and several civil servants. Their actions triggered the FDA to release a rebuke of the company to set the record straight about the trial results. This toxic group continues to generate disinformation in it's echo chamber and engages in disinformation/harassment campaigns from time to time.
General Competency
Those at the helm of CYDY have repeatedly failed to get filings, trials and deadlines right. Nader's wild misstatements and compensation plan have attracted lawsuits, investigations and an attempted coup by a 13D group. It should be noted that every business Nader has run previously ended in bankruptcy, and one was engaged in the fraudulent sale of Indian Art.
These are the perils facing the company at this time.
